164 related articles for article (PubMed ID: 16953823)
1. Chemically modified tetracyclines stimulate matrix metalloproteinase-2 production by periodontal ligament cells.
Bildt MM; Snoek-Van Beurden AM; DeGroot J; Van El B; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontal Res; 2006 Oct; 41(5):463-70. PubMed ID: 16953823
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR
Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
[TBL] [Abstract][Full Text] [Related]
4. Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition.
Salo T; Soini Y; Oiva J; Kariylitalo ; Nissinen A; Biancari F; Juvonen T; Satta J
Int J Cardiol; 2006 Aug; 111(3):358-64. PubMed ID: 16242193
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of MMP-13 by chemical modified tetracyclines in osteoblasts.
Kirkwood K; Martin T; Agnello K; Kim YJ
J Int Acad Periodontol; 2004 Apr; 6(2):39-46. PubMed ID: 15125014
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction.
Raulo SM; Sorsa T; Maisi P
Am J Vet Res; 2006 Jul; 67(7):1252-7. PubMed ID: 16817751
[TBL] [Abstract][Full Text] [Related]
7. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
[TBL] [Abstract][Full Text] [Related]
8. Induction of MMP-2 at the interface between epithelial cells and fibroblasts from human periodontal ligament.
Shimonishi M; Takahashi I; Terao F; Komatsu M; Kikuchi M
J Periodontal Res; 2010 Jun; 45(3):309-16. PubMed ID: 19909403
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Tsai CH; Hsieh YS; Yang SF; Chou MY; Chang YC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):710-6. PubMed ID: 12789153
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of matrix metalloproteinases by black-pigmented Bacteroides in human pulp and periodontal ligament cell cultures.
Chang YC; Lai CC; Yang SF; Chan Y; Hsieh YS
J Endod; 2002 Feb; 28(2):90-3. PubMed ID: 11833696
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontal Res; 2009 Apr; 44(2):266-74. PubMed ID: 18973523
[TBL] [Abstract][Full Text] [Related]
12. Chemically modified tetracyclines induce apoptosis in cultured mast cells.
Sandler C; Nurmi K; Lindstedt KA; Sorsa T; Golub LM; Kovanen PT; Eklund KK
Int Immunopharmacol; 2005 Oct; 5(11):1611-21. PubMed ID: 16039551
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of collagen, lysyl oxidase and MMP-2 in human periodontal ligament cells by low- and high-level mechanical stretching.
Chen YJ; Jeng JH; Chang HH; Huang MY; Tsai FF; Yao CC
J Periodontal Res; 2013 Aug; 48(4):466-74. PubMed ID: 23190051
[TBL] [Abstract][Full Text] [Related]
14. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.
Marcial BL; Sousa SF; Barbosa IL; Dos Santos HF; Ramos MJ
J Phys Chem B; 2012 Nov; 116(46):13644-54. PubMed ID: 23121406
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
17. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Qu X; Yuan Y; Xu W; Chen M; Cui S; Meng H; Li Y; Makuuchi M; Nakata M; Tang W
Anticancer Res; 2006; 26(5A):3573-8. PubMed ID: 17094485
[TBL] [Abstract][Full Text] [Related]
18. Relaxin stimulates MMP-2 and alpha-smooth muscle actin expression by human periodontal ligament cells.
Henneman S; Bildt MM; Degroot J; Kuijpers-Jagtman AM; Von den Hoff JW
Arch Oral Biol; 2008 Feb; 53(2):161-7. PubMed ID: 17920032
[TBL] [Abstract][Full Text] [Related]
19. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
Naruse K; Lash GE; Innes BA; Otun HA; Searle RF; Robson SC; Bulmer JN
Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes.
Uitto VJ; Firth JD; Nip L; Golub LM
Ann N Y Acad Sci; 1994 Sep; 732():140-51. PubMed ID: 7978787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
